Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1653, 2008-01, pp. : 23-23
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Mifeprex: two additional sepsis deaths reported to US FDA
Reactions Weekly, Vol. 1, Iss. 1094, 2006-01 ,pp. :
The US FDA and the flow of health economics information
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 285, 2000-01 ,pp. :
FDA requests Boxed Warnings on conventional antipsychotics
Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. :
FDA requests class label change for atypical antipsychotics
Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. :
The US Cymbalta [duloxetine] label will be updated with additional information on hepatotoxicity
Reactions Weekly, Vol. 1, Iss. 1074, 2005-01 ,pp. :